Arthur Elliot Hirshorn alias Dr. 85-Marker Mirage

Arthur Elliot Hirshorn is not licensed or approved by South Carolina Board of Chiropractic Examiners to diagnose, treat, or cure There are 24 distinct patterns of thyroid dysfunction..

There are 24 distinct patterns of thyroid dysfunction.

Supports

High‑quality thyroid literature consistently describes a limited number of biochemical patterns of thyroid dysfunction, most commonly overt hypothyroidism, overt hyperthyroidism, subclinical hypothyroidism, and subclinical hyperthyroidism, sometimes further divided by severity bands of TSH (e. ^[9][10] g. , mild vs marked elevation, low but detectable vs clearly suppressed). These are standard biochemical classifications supported by major reviews and guidelines, not a large, fixed set like 24 distinct patterns. ^[2] Systematic evidence reviews on thyroid screening and classification describe these few core categories and their severity strata, but do not enumerate 24 distinct patterns as a recognized framework. ^[11][12] Large epidemiologic and clinical cohorts similarly report a small number of thyroid dysfunction types (overt hypo/hyper, subclinical hypo/hyper, central hypothyroidism, drug‑induced forms), and while they may stratify by antibody status, etiology, or imaging findings, they do not claim 24 distinct dysfunction patterns as a standard taxonomy.

Contradicts

No guideline, systematic review, or major classification paper identifies exactly 24 distinct patterns of thyroid dysfunction as a recognized or clinically used scheme. ^[9][11][12] The mainstream biochemical classifications describe a small set of core dysfunction states (euthyroid, overt hypothyroidism, overt hyperthyroidism, subclinical hypothyroidism, subclinical hyperthyroidism, and central hypothyroidism) with further grading by TSH level, symptoms, or antibodies, but these refinements produce flexible categories rather than a fixed count of 24. ^[10] Where studies introduce more granular subtypes (for example, based on autoantibody patterns, imaging findings, or specific drug‑induced mechanisms), they do so for research stratification and do not present or validate a universal 24‑pattern classification. There is no high‑quality evidence (RCTs, meta‑analyses, major guidelines) that uses, tests, or endorses an influencer‑style list of 24 discrete thyroid dysfunction patterns as an accepted diagnostic framework, so the numerical claim is not supported and likely reflects an idiosyncratic or marketing‑driven scheme rather than evidence‑based medicine. ^[1][2][6]

Mainstream view

The mainstream medical view is that thyroid dysfunction is classified into a small number of well‑defined categories based on thyroid‑stimulating hormone (TSH), free thyroxine (FT4), and sometimes free triiodothyronine (FT3), plus etiology (autoimmune, nodular, central/pituitary, drug‑induced) and severity. ^[9][12] Clinically important categories include overt hypothyroidism, overt hyperthyroidism, subclinical hypothyroidism, subclinical hyperthyroidism, and central hypothyroidism, with additional descriptors for autoimmune thyroiditis, Graves’ disease, nodular goiter, and specific drug‑induced conditions. ^[10][11] Guidelines and evidence reviews emphasize accurate biochemical classification, identification of cause, and grading of severity, not assignment into a large fixed number of “patterns” like 24. ^[2][6] Any finer stratification (for example, by antibody pattern or imaging features) is used for risk stratification or research, and does not constitute a universally accepted 24‑pattern taxonomy. Therefore, the mainstream position does not recognize “24 distinct patterns of thyroid dysfunction” as an evidence‑based or standard concept. ^[1]

▶ 0:39In their own wordsWatch at 0:39

“At New Life Health, we understand that there are 24 different patterns of thyroid dysfunction.”

Rule: S.C. Code § 40-9-10(b)-(c); S.C. Code Regs. 25-5(A)

See every doc bro who says they can treat or advise on Thyroid disease and Hashimoto

Arthur Elliot Hirshorn is not licensed or approved by South Carolina Board of Chiropractic Examiners to diagnose, treat, or cure Over 80% of thyroid symptom cases are autoimmune (Hashimoto's) and the immune system is attacking the thyroid..

Over 80% of thyroid symptom cases are autoimmune (Hashimoto's) and the immune system is attacking the thyroid.

Supports

High-quality reviews and reference sources agree that autoimmune thyroid disease, particularly Hashimoto’s thyroiditis, is the most common cause of primary hypothyroidism in iodine‑sufficient regions. Multiple reviews and textbook chapters state that an autoimmune cause accounts for a large majority (often cited around 80–90%) of adult primary hypothyroidism, mostly due to Hashimoto’s disease, which is characterized by immune-mediated destruction of thyroid tissue.^[10] Hashimoto’s thyroiditis is widely described as the leading cause of hypothyroidism in iodine-sufficient areas and the most common autoimmune thyroid disorder.^{[8][9][16][22]} Systematic and scoping reviews of autoimmune thyroid disease show that autoimmune thyroiditis is highly prevalent and that, in cohorts of patients with hypothyroidism, the predominant etiology is autoimmune (anti‑TPO–positive) thyroiditis, with figures near 79% in some clinical series.^[13] These data support the general idea that the immune system attacking the thyroid (autoimmune thyroiditis, including Hashimoto’s) is the main cause of hypothyroidism and thyroid-related symptoms in adults in iodine-sufficient populations, and that a high proportion—on the order of 80% in many clinical cohorts—of hypothyroid cases are autoimmune in origin.

Contradicts

The influencer’s statement is framed broadly as “over 80% of thyroid symptom cases,” which is more expansive and less precise than the epidemiologic literature, which usually addresses primary hypothyroidism (overt or subclinical) rather than all “thyroid symptom cases” regardless of cause. Evidence shows substantial regional variation in Hashimoto’s and autoimmune thyroid disease prevalence, with global Hashimoto’s prevalence estimates around 5–10% overall and marked differences between countries and subgroups, indicating that the proportion of thyroid cases that are autoimmune is not a fixed universal number.^[8][18] In iodine-deficient regions or in specific populations, non‑autoimmune causes such as iodine deficiency, prior thyroid surgery, radioiodine treatment, certain drugs, or transient thyroiditis are important contributors to thyroid dysfunction, so the proportion attributable to Hashimoto’s can be lower than 80% in those contexts.^[8][20][22] Moreover, not all individuals with thyroid‑related symptoms have hypothyroidism or autoimmune disease; many are euthyroid, have nodular disease, or have nonthyroidal conditions, so saying “over 80% of thyroid symptom cases” are autoimmune overgeneralizes beyond the populations studied in the literature, where the 80–90% figure refers specifically to adult primary hypothyroidism in iodine‑sufficient areas.^[10][22] Overall, while autoimmune causes predominate in many adult hypothyroid cohorts, the influencer’s wording is somewhat misleading because it implies a universal, symptom‑based proportion rather than a context‑dependent, disease‑based proportion.

Mainstream view

Mainstream endocrinology holds that Hashimoto’s thyroiditis and related autoimmune thyroid diseases are the leading causes of primary hypothyroidism in iodine‑sufficient regions, and that most adult primary hypothyroidism is autoimmune in origin, reflecting immune-mediated destruction of the thyroid.^{[8][10][16][22]} Clinical guidelines and reviews emphasize that anti‑TPO and other thyroid autoantibodies are common in hypothyroid patients and that autoimmunity is the predominant etiology, but they also stress that the exact proportion varies by age, sex, iodine status, and population, and that non‑autoimmune causes (iodine deficiency, surgery, radioiodine, drugs, transient thyroiditis, central hypothyroidism) remain important contributors. Thus the mainstream view is that “most” adult primary hypothyroidism cases are autoimmune in iodine‑replete settings, but it avoids oversimplified or universal claims about all “thyroid symptom cases,” recognizing heterogeneity across populations and disease categories.^{[8][10][18][20][22]}

▶ 1:01In their own wordsWatch at 1:01

“for over 80% of people struggling with thyroid-related symptoms, there's often an autoimmune component, meaning your thyroid may not actually be the root problem. Your immune system may be attacking your thyroid”

Rule: S.C. Code § 40-9-10(a)-(c); S.C. Code Regs. 25-5(A)

See every doc bro who says they can treat or advise on Thyroid disease and Hashimoto

Arthur Elliot Hirshorn is not licensed or approved by South Carolina Board of Chiropractic Examiners to diagnose, treat, or cure We use a proprietary 85-marker comprehensive panel to diagnose root causes of thyroid dysfunction..

We use a proprietary 85-marker comprehensive panel to diagnose root causes of thyroid dysfunction.

Supports

Mainstream diagnostic strategies for thyroid dysfunction rely on a relatively small set of well‑validated laboratory markers (TSH, free T4, free T3, and thyroid autoantibodies), not dozens of additional markers, and these core tests can reliably diagnose hypothyroidism and hyperthyroidism in most patients.^{[1][3][4][6][12]} Some research explores additional molecular or inflammatory biomarkers (such as microbiota‑driven markers, osteopontin, visfatin, melatonin, TNF‑α, IL‑6, nitrosative stress markers, etc.) as potential adjuncts or early indicators in thyroid disease, suggesting that multi‑marker panels could theoretically be developed in the future.^{[18][19][21][24]} These exploratory studies show associations and modest diagnostic performance for selected non‑traditional markers, which conceptually supports the idea that extended panels might add information about comorbidities or disease mechanisms beyond simple thyroid hormone measurements.^{[16][18][19][21][24]}

Contradicts

High‑quality guidelines and reviews consistently state that thyroid dysfunction is effectively diagnosed using a limited set of core tests (TSH plus free T4, with free T3 and thyroid autoantibodies when indicated), and do not recommend large proprietary panels with dozens of markers for routine diagnosis.^{[1][3][4][6][7][8][12]} There is no guideline, systematic review, or major randomized trial supporting the need for or superiority of an 85‑marker or similarly large “comprehensive” panel to identify the root causes of thyroid dysfunction in typical clinical practice.^{[1][3][4][6][12]} Existing research on novel biomarkers (e.g., gut microbiota‑related markers, osteopontin, visfatin, melatonin, TNF‑α, APOE expression) is exploratory, often small and observational, and does not establish validated diagnostic cutoffs or demonstrate that adding many such markers to a panel improves diagnostic accuracy, outcomes, or cost‑effectiveness compared with standard thyroid testing.^{[18][19][21][24]} Guidelines emphasize stepwise or cascaded testing starting with TSH and then a few additional assays rather than broad multi‑marker screening, underscoring that extensive panels are not standard of care.^{[3][4][6][12]}

Mainstream view

The mainstream medical position is that thyroid dysfunction is diagnosed primarily with serum TSH and free T4, with free T3 and thyroid autoantibodies (such as TPO and thyroglobulin antibodies) added based on the clinical scenario, and that this limited set of tests is sufficient for accurate diagnosis in the vast majority of patients.^{[1][3][4][6][7][8][12]} Major guidelines and authoritative reviews endorse TSH (often as the first‑line test) plus free thyroid hormone measurements as the principal and definitive laboratory tools; they do not endorse large proprietary multi‑marker panels for routine assessment of thyroid dysfunction or for determining its “root causes.”^{[3][4][6][12]} Research on novel or extended biomarker sets is viewed as investigational and, at present, is considered adjunctive at best rather than a replacement for or required addition to standard thyroid function testing.^{[18][19][21][24]}

▶ 2:54In their own wordsWatch at 2:54

“We start with a comprehensive panel of over 85 markers, including 10 thyroid-specific markers”

Rule: S.C. Code Regs. 25-5(A)(4); S.C. Code § 40-9-10(b)-(c)

See every doc bro who says they can treat or advise on Thyroid disease and Hashimoto

Arthur Elliot Hirshorn is not licensed or approved by South Carolina Board of Chiropractic Examiners to diagnose, treat, or cure We provide a personalized root-cause plan to reverse thyroid symptoms, rejecting standard 'cookie cutter' medication protocols..

We provide a personalized root-cause plan to reverse thyroid symptoms, rejecting standard 'cookie cutter' medication protocols.

Supports

There is emerging interest in more personalized approaches to managing thyroid disease, including adjusting levothyroxine dose based on individual pharmacokinetics, comorbidities, and patient-reported outcomes, rather than purely on TSH thresholds. Some observational and small interventional studies explore multifactorial, individualized management (e. g. , assessing autoimmunity, iodine status, concurrent medications, and comorbid conditions) to optimize thyroid symptom control, but these are not generally framed as “root-cause plans” and rarely demonstrate robust reversals of symptoms beyond what standard guideline-based care achieves. ^[1] This represents exploratory work rather than high-quality, definitive evidence. Major guideline frameworks such as GRADE emphasize tailoring decisions to patient values and preferences once evidence on benefits and harms is appraised, acknowledging that strict one-size-fits-all protocols may not fit every patient, but they still rely on standardized medication strategies as the backbone of care. ^[6][4]

Contradicts

High-quality evidence and major thyroid guidelines consistently support standardized, evidence-based protocols—centered on appropriate thyroid hormone replacement or antithyroid medication—as the foundation of care rather than unvalidated “root-cause reversal” programs. ^[5][6] Large randomized trials and meta-analyses of levothyroxine therapy in hypothyroidism show that pharmacologic replacement using guideline-directed dosing normalizes thyroid indices and improves typical symptoms in most patients; no comparable high-quality evidence shows that personalized non-standard root-cause plans can systematically reverse thyroid symptoms or outperform standard care. ^[7] Established guideline methodology (e. g. , GRADE) highlights that recommendations should be based on the balance of benefits, harms, and quality of evidence and warns against strong claims when evidence is indirect, imprecise, or low quality. The available literature on lifestyle or supplement-based thyroid symptom “reversal” is generally small, heterogeneous, and at high risk of bias, and does not justify broad claims that thyroid symptoms can be reversed by personalized root-cause plans in place of standard pharmacotherapy. Major clinical guidelines in other domains, such as nutrition support, headache, and hypertension, similarly emphasize protocolized, evidence-based treatment frameworks rather than rejecting them wholesale in favor of untested individualized programs. ^[1][2][3][4]

Mainstream view

The mainstream medical position is that thyroid disorders (such as hypothyroidism, hyperthyroidism, and autoimmune thyroid disease) should be treated primarily with standardized, guideline-based medication regimens—for example, thyroid hormone replacement for hypothyroidism, antithyroid drugs or radioactive iodine for hyperthyroidism—because these approaches are supported by robust randomized trials, long-term outcome data, and consensus guidelines. ^[1][2][3][4] Personalization is recommended within this framework (dose titration, attention to comorbidities, patient preference, and monitoring of both labs and symptoms), but mainstream endocrinology does not endorse abandoning evidence-based medication protocols in favor of proprietary root-cause plans claiming to reverse thyroid symptoms. The GRADE guideline framework and other major guidelines in diverse areas of medicine reinforce that individualized care should be built on a foundation of standardized, rigorously evaluated treatments rather than on unproven, highly personalized programs. ^[6]

▶ 2:17In their own wordsWatch at 2:17

“my expert team uses the same root cause system we've built over the last 13 plus years to help patients uncover what standard thyroid evaluations often miss.”

Rule: S.C. Code § 40-9-10(b); S.C. Code Regs. 25-5(A)

See every doc bro who says they can treat or advise on Thyroid disease and Hashimoto

Arthur Elliot Hirshorn is not licensed or approved by South Carolina Board of Chiropractic Examiners to diagnose, treat, or cure Thyroid consultation service.

Thyroid consultation service

No specific health claims of theirs were cross-checked against the literature.

▶ 3:36In their own wordsWatch at 3:36

“schedule your thyroid consultation with our expert team”

Rule: S.C. Code § 40-9-10(a)-(c); S.C. Code Regs. 25-5(A)

See every doc bro who says they can treat or advise on Thyroid disease and Hashimoto